Peter Salzmann - 18 May 2023 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Sean Moran, attorney-in-fact for Peter Salzmann
Issuer symbol
CRBP
Transactions as of
18 May 2023
Net transactions value
$0
Form type
4
Filing time
22 May 2023, 16:24:56 UTC
Previous filing
19 Apr 2023
Next filing
13 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option (right to buy) Award $0 +5,300 $0.000000 5,300 18 May 2023 Common Stock 5,300 $9.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest 100% on the one year anniversay from the date of grant.